No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism*
-
Breast Neoplasms / drug therapy
-
Carcinoma, Non-Small-Cell Lung / drug therapy
-
Clinical Trials as Topic / standards*
-
Cyclin D1 / metabolism
-
ErbB Receptors / metabolism
-
Female
-
Humans
-
Lung Neoplasms / drug therapy
-
Mutation
-
Neoplasms / metabolism
-
Neoplasms / therapy*
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins B-raf / metabolism
-
Proto-Oncogene Proteins p21(ras)
-
Research Design / standards*
-
Retinoid X Receptors / metabolism
-
Vascular Endothelial Growth Factor A / metabolism
-
ras Proteins / metabolism
Substances
-
Biomarkers, Tumor
-
CCND1 protein, human
-
KRAS protein, human
-
Proto-Oncogene Proteins
-
Retinoid X Receptors
-
Vascular Endothelial Growth Factor A
-
Cyclin D1
-
ErbB Receptors
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins